Obesity May Alter Inflammation on a Molecular Level, Throwing Current Treatments into Question
Obesity May Alter Inflammation on a Molecular Level, Throwing Current Treatments into Question
Fierce Biotech—Alexander Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues at UC San Francisco and the Salk Institute for Biological Studies, recently showed that obese mice with atopic dermatitis had an altered immune response that made them refractory to anti-inflammatory treatment. Fierce Biotech discusses the implications of this finding for the development of drugs against inflammation and asthma.
Gladstone Experts Genomic Immunology Marson Lab Disease Models